Gelomirtol forte caps. enteric. 300 mg per blister. in pack No. 10x2 (myrtol)

Compound

GeloMyrtol® forte

GeloMyrtol®

Gelomirtol's analogs

Level 4 ATC code matches: Cashnol
Anise oil

Bronchophyte

Pine buds

Pertussin

Bronchosan

Gedelix

Mixture for inhalation

Herbion ivy syrup

Herbion plantain syrup

Herbion primrose syrup

Mukaltin

Sinupret Forte

Dr. Theiss syrup with plantain

Bronchosept

Joset

Thermopsol

Tussamag

Marshmallow syrup

Dry cough syrup

There are no analogues of Gelomirtol Forte and Gelomirtol.

Directions for use and doses

Orally, 30 minutes before meals, with a sufficient amount of water at room temperature.

GeloMyrtol® forte

Adults and children over 10 years old

Adults: for acute inflammation - 1 caps. 3–4 times a day; for chronic inflammation - 1 caps. 2 times a day; to facilitate sputum discharge in the morning - an additional 1 capsule. before bedtime.

Children from 10 to 18 years old: for acute inflammation - 1 caps. 2 times a day; for chronic inflammation - 1 caps. in a day.

The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

GeloMyrtol®

Adults and children over 6 years old

Adults: for acute inflammation - 2 caps. 4–5 times a day (8–10 capsules per day); for chronic inflammation - 2 caps. 3 times a day; to facilitate sputum discharge in the morning - an additional 2 caps. before bedtime (8 capsules per day).

Children from 6 to 10 years old: for acute inflammation - 1 caps. 3–4 times a day; for chronic inflammation - 1 caps. 2–3 times a day.

Children from 10 to 18 years old: for acute inflammation - 1 caps. 4–5 times a day; for chronic inflammation - 1 caps. 2–3 times a day.

The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

Gelomirtol Forte enteric capsules 300 mg No. 10x2

Name

Gelomirtol Forte caps. intestinal 300 mg per bl. in pack №10x2

Description

GeloMyrtol® forte. Soft gelatin capsules, transparent, oblong. The contents of the capsules are a clear, colorless liquid with a characteristic odor.

Main active ingredient

Myrtol

Release form

GeloMyrtol® forte. Enteric capsules. 10 caps. in a blister made of laminated and aluminum foil. 2 blisters (20 capsules) in a cardboard box.

Dosage

300 mg

pharmachologic effect

Expectorants, except in combination with antitussives. This drug facilitates the discharge of sputum in acute and chronic bronchitis, and also alleviates the symptoms of sinusitis. The active ingredients of the GeloMyrtol® capsule help to liquefy and reduce the viscosity of sputum and nasopharyngeal secretions and improve their evacuation. If you do not feel better, or if you feel worse after 10 days, you should see your doctor.

Pharmacodynamics

It has mucolytic, anti-inflammatory, antibacterial effects.

Pharmacokinetics

After oral administration, it is well absorbed in the small intestine. Cmax in blood plasma is achieved 1–3 hours after taking the drug. Approximately 60% of the drug and its metabolites are excreted in the urine, 5% in the feces, and about 2% in the lungs. Can penetrate the placental barrier; into the milk of lactating women.

Indications for use

Complex therapy of inflammatory diseases of the respiratory tract (acute and chronic bronchitis, sinusitis).

Directions for use and doses

GeloMyrtol® forte Adults and children over 10 years old Adults: for acute inflammation - 1 caps. 3–4 times a day; for chronic inflammation - 1 caps. 2 times a day; to facilitate sputum discharge in the morning - an additional 1 capsule. before bedtime. Children from 10 to 18 years old: for acute inflammation - 1 caps. 2 times a day; for chronic inflammation - 1 caps. in a day. The duration of treatment depends on the severity of the symptoms of the disease and is determined by the attending physician.

Use during pregnancy and lactation

If you are pregnant or breastfeeding, or think you may be pregnant or planning to have a baby, check with your doctor or pharmacist before taking this drug. Pregnancy: Animal studies have not shown any direct or indirect harmful effects on the fetus in the womb. Animal studies, as well as many years of therapeutic experience with GeloMyrtol® capsules, do not show direct or indirect harmful effects on the fetus in the womb. Therefore, capsules can be used during pregnancy if clinically indicated. As with any medication during pregnancy, you should consult your doctor before using GeloMyrtol® capsules during this period. Breastfeeding: Due to the fat-soluble properties of the active substance, it can be assumed that its components are also present in low concentrations in breast milk. There is still no evidence of any risks when using GeloMyrtol® during breastfeeding. As with any medication while breastfeeding, you should consult your doctor before using capsules during this period. Fertility: Animal studies have shown no direct or indirect harmful effects on fertility. Driving and using machinery No special precautions are required.

Precautionary measures

Before you start taking GeloMyrtol®, consult your doctor or pharmacist - If your symptoms persist or worsen, or you develop shortness of breath or fever, or if you have sputum that contains blood or pus, you should contact your doctor immediately. — If you suffer from bronchial asthma, whooping cough or other respiratory diseases accompanied by severe hypersensitivity of the respiratory system, you should take GeloMyrtol® capsules after consultation with your doctor. The contents of the capsule should not be used for inhalation to treat children. GeloMyrtol® contains sorbitol. If your doctor has told you that you have an intolerance to certain types of sugar, contact your doctor before taking GeloMyrtol®.

Interaction with other drugs

If the drug is taken as recommended, there are no known interactions with other medications.

Contraindications

Do not take GeloMyrtol®

• if you have an inflammatory disease of the stomach, intestines or biliary tract, or if you have severe liver disease,
• if you are allergic (hypersensitive) to the active ingredient or any other ingredients (listed in section 6).

GeloMyrtol® should not be taken by children under 6 years of age.

Compound

Active Ingredient: One capsule contains 120 mg distillate of a mixture of purified essential oils of eucalyptus, sweet orange, myrtle and lemon (66:32:1:1). Other Ingredients: Medium chain triglycerides, gelatin, glycerin, sorbitol, 13% hydrochloric acid solution, hypromellose acetate succinate, triethyl citrate, sodium lauryl sulfate, talc, dextrin, ammonium glycyrrhizinate. What the package looks like and contents Soft oval translucent gelatin capsules, beige. The package contains 20 enteric capsules. 10 capsules in a blister. 2 blisters and instructions for use in a folding box.

Overdose

Symptoms: in case of accidental overdose, nausea, vomiting, convulsions are possible, in severe cases - coma or breathing problems. In rare cases, after severe intoxication, disturbances in the activity of the cardiovascular system are possible. Treatment: administration of petroleum jelly at a dose of 3 ml/kg; gastric lavage with 5% sodium bicarbonate solution (baking soda); ventilation of the lungs with oxygen.

Side effect

Common: pain in the stomach and abdomen. Uncommon: allergic reactions (such as shortness of breath, swelling of the face, rash, urticaria, itching); gastritis and gastroenteritis, nausea, vomiting, diarrhea or other digestive disorders; change in taste; headaches or dizziness. Very rare: movement of existing kidney and gallstones. Not known (frequency not established): severe anaphylactic reactions. Reporting side effects If you experience side effects, contact your doctor or pharmacist. This applies to any possible side effects not listed in these instructions for use.

Storage conditions

Store in original packaging to protect from moisture, at a temperature not exceeding 25°C. Keep out of the reach of children. Do not use this medicinal product after the expiration date indicated on the box and blister after the words “Best before”. The expiration date refers to the last day of the indicated month.

Buy Gelomirtol Forte caps. intestinal 300 mg per bl. in pack No. 10x2 in the pharmacy

Price for Gelomirtol Forte caps. intestinal 300 mg per bl. in pack №10x2

Instructions for use for Gelomirtol Forte caps. intestinal 300 mg per bl. in pack №10x2

Reviews about Gelomirtol

Reviews of Gelomirtol Forte speak of it as an effective medicine for the treatment of tracheitis , sinusitis , bronchitis , both in combination therapy and when taken independently. There are many reviews that even antibiotics with bronchitis, and after a course of treatment with this medicine, all symptoms quickly disappear: first, sputum , and then the cough completely disappears. Use for sinusitis makes breathing easier, and the sinuses are cleared of purulent contents faster.

Many are attracted by the naturalness of the drug and ease of use. There are several reviews about the presence of side effects - stomach pain and nausea.

Note!

Description of the drug Gelomirtol forte caps. 300 mg No. 20 on this page is a simplified author’s version of the apteka911 website, created on the basis of the instructions for use.
Before purchasing or using the drug, you should consult your doctor and read the manufacturer's original instructions (attached to each package of the drug). Information about the drug is provided for informational purposes only and should not be used as a guide to self-medication. Only a doctor can decide to prescribe the drug, as well as determine the dose and methods of its use.

Gelomirtol price, where to buy

The price of Gelomirtol Forte in Russia is about 258 rubles. per pack of 20 capsules, and the dose is 120 mg. costs 186 rubles.

In Ukraine, the cost of a dosage is 120 mg. 74 UAH, and 300 mg - 94 UAH. for 20 capsules.

• Online pharmacies in UkraineUkraine

Pharmacy24

• GeloMyrtol 120 mg No. 20 capsules G. Pohl-Boskamp GmbH & Co. KG, Germany
  158 UAH order
• GeloMyrtol forte 300 mg No. 20 capsules G. Pohl-Boskamp GmbH & Co. KG, Germany

  188 UAH order

special instructions

If the symptoms of the disease do not disappear or the patient’s condition worsens, if shortness of breath appears, body temperature rises, blood or pus appears in the sputum, you should immediately consult a doctor.

Patients with asthma or whooping cough should consult a doctor before using the drug.

During pregnancy and breastfeeding. Although there is no information about the negative effects of the drug Gelomirtol on the fetus, during pregnancy and lactation it is taken only under the supervision of a doctor, especially in the first trimester.

Children. Gelomirtol is used in children aged from 3 years, and Gelomirtol forte - from 6 years.

Influence on reaction speed when driving vehicles and working with other mechanisms. No data.

Pharmacological properties

Expectorant.
Gelomyrtol contains as an active substance an essential oil of plant origin - standardized myrtol. Myrtol standardized has secretomotor and secretolytic effects, which contribute to the liquefaction of sputum, activation of the mucociliary epithelium and, as a result, intensive production of sputum. When used in high doses, standardized myrtol also has antimicrobial, immunomodulatory, antispasmodic and vasodilatory effects.

Pharmacokinetics have not been studied.